title: Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex.
abstract: Despite the tremendous importance of D1 and NMDA receptors to cognition (working memory, executive functions) and synaptic plasticity in the prefrontal cortex (PFC), little is known about the molecular mechanisms underlying D1-NMDA receptors interactions in this brain area. Here, we show that D1 receptors and the NMDA receptor co-localize in single pyramidal neurons and interneurons in adult rat PFC. NR1 and NR2A expression are found in different neuronal types. Conversely, D1 receptors are predominantly localized in pyramidal-like cells and parvalbumin positive cells. NR1 co-immunoprecipitates with D1 receptor in adult medial PFC. In prefrontal primary cultures, NMDA does not affect the D1 receptor dependent-cAMP production. In contrast, activation of D1 receptor potentiates the NMDA mediated increase in cytosolic Ca2+, an effect that was blocked by a PKA inhibitor. We conclude that D1 receptor potentiates the NMDA-Ca2+ signal by a PKA-dependent mechanism.
authors.affiliation: INSERM, U894, Physiopathologie des Maladies Psychiatriques, Centre de psychiatrie et Neurosciences, Paris, France. kruse@dna.uba.ar
authors.forename: Maria Sol
authors.initials: MS
authors.lastname: Kruse
authors.forename: Joël
authors.initials: J
authors.lastname: Prémont
authors.forename: Marie-Odile
authors.initials: MO
authors.lastname: Krebs
authors.forename: Thérèse M
authors.initials: TM
authors.lastname: Jay
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D004622:Embryo, Mammalian; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D047468:Immunoprecipitation / Q000379:methods; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology; D016202:N-Methylaspartate / Q000494:pharmacology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000819:agonists / Q000378:metabolism*; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D001552:Benzazepines; D004791:Enzyme Inhibitors; D007546:Isoquinolines; C409466:NR1 NMDA receptor; D017447:Receptors, Dopamine D1; D016194:Receptors, N-Methyl-D-Aspartate; D013449:Sulfonamides; D016202:N-Methylaspartate; C067113:SK&F 81297; D000242:Cyclic AMP; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide; D002118:Calcium; D005998:Glycine